Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Tam

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 28, 2022
Hepatic targeting of the centrally active cannabinoid 1 receptor (CB<sub>1</sub>R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetesShira Hirsch, Liad Hinden, Meital Ben-David Naim, et al.
World Neurosurgery|July 18, 2016
Social Media for Academic Neurosurgical Programs: The University of Toronto ExperienceNaif M Alotaibi, Nardin Samuel, Daipayan Guha, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2014
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathyTony Jourdan, Gergő Szanda, Avi Z Rosenberg, et al.
Translational Psychiatry|July 2, 2025
Characterization of Neurensin-2 knockout mice: insights into stress-resilience mechanismsHadas Catane Hovav, Ofer Yitzhak Kashi, Yumna Abu Ghanem, et al.
British Journal of Pharmacology|March 5, 2026
Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restorationRadka Kočvarová, Shahar Azar, Bella Agranovich, et al.
International Journal of Molecular Sciences|September 9, 2022
Blood RNA Sequencing Indicates Upregulated <i>BATF2</i> and <i>LY6E</i> and Downregulated <i>ISG15</i> and <i>MT2A</i> Expression in Children with Autism Spectrum DisorderIrena Voinsky, Yazeed Zoabi, Noam Shomron, et al.
The Journal of Clinical Investigation|July 29, 2010
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesityJoseph Tam, V Kiran Vemuri, Jie Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
Peripheral cannabinoid receptor, CB2, regulates bone massOrr Ofek, Meliha Karsak, Nathalie Leclerc, et al.
Molecular Metabolism|December 23, 2023
Lysine tRNA fragments and miR-194-5p co-regulate hepatic steatosis via β-Klotho and perilipin 2Yonat Tzur, Katarzyna Winek, Nimrod Madrer, et al.
Iscience|February 6, 2024
Characterization of metabolic alterations in the lean metabolically unhealthy alpha defensin transgenic miceAbd Al-Roof Higazi, Emad Maraga, Saja Baraghithy, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 28, 2022
Hepatic targeting of the centrally active cannabinoid 1 receptor (CB<sub>1</sub>R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetesShira Hirsch, Liad Hinden, Meital Ben-David Naim, et al.
World Neurosurgery|July 18, 2016
Social Media for Academic Neurosurgical Programs: The University of Toronto ExperienceNaif M Alotaibi, Nardin Samuel, Daipayan Guha, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2014
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathyTony Jourdan, Gergő Szanda, Avi Z Rosenberg, et al.
Translational Psychiatry|July 2, 2025
Characterization of Neurensin-2 knockout mice: insights into stress-resilience mechanismsHadas Catane Hovav, Ofer Yitzhak Kashi, Yumna Abu Ghanem, et al.
British Journal of Pharmacology|March 5, 2026
Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restorationRadka Kočvarová, Shahar Azar, Bella Agranovich, et al.
International Journal of Molecular Sciences|September 9, 2022
Blood RNA Sequencing Indicates Upregulated <i>BATF2</i> and <i>LY6E</i> and Downregulated <i>ISG15</i> and <i>MT2A</i> Expression in Children with Autism Spectrum DisorderIrena Voinsky, Yazeed Zoabi, Noam Shomron, et al.
The Journal of Clinical Investigation|July 29, 2010
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesityJoseph Tam, V Kiran Vemuri, Jie Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
Peripheral cannabinoid receptor, CB2, regulates bone massOrr Ofek, Meliha Karsak, Nathalie Leclerc, et al.
Molecular Metabolism|December 23, 2023
Lysine tRNA fragments and miR-194-5p co-regulate hepatic steatosis via β-Klotho and perilipin 2Yonat Tzur, Katarzyna Winek, Nimrod Madrer, et al.
Iscience|February 6, 2024
Characterization of metabolic alterations in the lean metabolically unhealthy alpha defensin transgenic miceAbd Al-Roof Higazi, Emad Maraga, Saja Baraghithy, et al.
Pageof 13